BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9582016)

  • 1. Activation of the Xmrk proto-oncogene of Xiphophorus by overexpression and mutational alterations.
    Dimitrijevic N; Winkler C; Wellbrock C; Gómez A; Duschl J; Altschmied J; Schartl M
    Oncogene; 1998 Apr; 16(13):1681-90. PubMed ID: 9582016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma loss-of-function mutants in Xiphophorus caused by Xmrk-oncogene deletion and gene disruption by a transposable element.
    Schartl M; Hornung U; Gutbrod H; Volff JN; Wittbrodt J
    Genetics; 1999 Nov; 153(3):1385-94. PubMed ID: 10545466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activation of the melanoma inducing Xmrk oncogene in Xiphophorus.
    Adam D; Mäueler W; Schartl M
    Oncogene; 1991 Jan; 6(1):73-80. PubMed ID: 1846957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The macromelanophore locus and the melanoma oncogene Xmrk are separate genetic entities in the genome of Xiphophorus.
    Weis S; Schartl M
    Genetics; 1998 Aug; 149(4):1909-20. PubMed ID: 9691046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-independent dimerization and activation of the oncogenic Xmrk receptor by two mutations in the extracellular domain.
    Gómez A; Wellbrock C; Gutbrod H; Dimitrijevic N; Schartl M
    J Biol Chem; 2001 Feb; 276(5):3333-40. PubMed ID: 11038352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression regulation triggers oncogenicity of xmrk alleles in the Xiphophorus melanoma system.
    Regneri J; Schartl M
    Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jan; 155(1):71-80. PubMed ID: 21527356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary origin and molecular biology of the melanoma-inducing oncogene of Xiphophorus.
    Schartl A; Dimitrijevic N; Schartl M
    Pigment Cell Res; 1994 Dec; 7(6):428-32. PubMed ID: 7761351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional control analyses of the Xiphophorus melanoma oncogene.
    Regneri J; Volff JN; Schartl M
    Comp Biochem Physiol C Toxicol Pharmacol; 2015 Dec; 178():116-127. PubMed ID: 26348392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Xmrk oncogene promoter is derived from a novel amplified locus of unusual organization.
    Förnzler D; Altschmied J; Nanda I; Kolb R; Baudler M; Schmid M; Schartl M
    Genome Res; 1996 Feb; 6(2):102-13. PubMed ID: 8919689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppression in Xiphophorus by an accidentally acquired promoter.
    Adam D; Dimitrijevic N; Schartl M
    Science; 1993 Feb; 259(5096):816-9. PubMed ID: 8430335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signalling by the oncogenic receptor tyrosine kinase Xmrk leads to activation of STAT5 in Xiphophorus melanoma.
    Wellbrock C; Geissinger E; Gómez A; Fischer P; Friedrich K; Schartl M
    Oncogene; 1998 Jun; 16(23):3047-56. PubMed ID: 9662338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of transcription of the melanoma inducing Xmrk oncogene by a GC box element.
    Baudler M; Duschl J; Winkler C; Schartl M; Altschmied J
    J Biol Chem; 1997 Jan; 272(1):131-7. PubMed ID: 8995238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction by the oncogenic receptor tyrosine kinase Xmrk in melanoma formation of Xiphophorus.
    Wellbrock C; Gómez A; Schartl M
    Pigment Cell Res; 1997; 10(1-2):34-40. PubMed ID: 9170160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the melanoma-inducing receptor tyrosine kinase Xmrk and src family tyrosine kinases in Xiphophorus.
    Wellbrock C; Lammers R; Ullrich A; Schartl M
    Oncogene; 1995 Jun; 10(11):2135-43. PubMed ID: 7540277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomethylation of the Xmrk oncogene promoter in melanoma cells of Xiphophorus.
    Altschmied J; Ditzel L; Schartl M
    Biol Chem; 1997 Dec; 378(12):1457-66. PubMed ID: 9461344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating mutations in the extracellular domain of the melanoma inducing receptor Xmrk are tumorigenic in vivo.
    Winnemoeller D; Wellbrock C; Schartl M
    Int J Cancer; 2005 Dec; 117(5):723-9. PubMed ID: 15957173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of phosphatidylinositol 3-kinase by a complex of p59fyn and the receptor tyrosine kinase Xmrk is involved in malignant transformation of pigment cells.
    Wellbrock C; Schartl M
    Eur J Biochem; 2000 Jun; 267(12):3513-22. PubMed ID: 10848967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-dependent tumor induction in medakafish embryos by a Xmrk receptor tyrosine kinase transgene.
    Winkler C; Wittbrodt J; Lammers R; Ullrich A; Schartl M
    Oncogene; 1994 Jun; 9(6):1517-25. PubMed ID: 8183545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3-kinase is involved in mitogenic signaling by the oncogenic receptor tyrosine kinase Xiphophorus melanoma receptor kinase in fish melanoma.
    Wellbrock C; Fischer P; Schartl M
    Exp Cell Res; 1999 Sep; 251(2):340-9. PubMed ID: 10471319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic, biochemical and evolutionary facets of Xmrk-induced melanoma formation in the fish Xiphophorus.
    Meierjohann S; Schartl M; Volff JN
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Jul; 138(3):281-9. PubMed ID: 15533786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.